| Palliative Care |
1 |
1 |
| Acute Pain |
0 |
0.68 |
| Pain Management |
0 |
0.55 |
| Anxiety Disorder |
0 |
0.53 |
| Cancer |
0 |
0.53 |
| Pain |
0 |
0.49 |
| Dentistry and Oral Health |
0 |
0.46 |
| Anxiety |
0 |
0.44 |
| Colorectal Cancer |
0 |
0.44 |
| Colon Cancer |
0 |
0.42 |
| Prostate Cancer |
0 |
0.4 |
| Advanced Cancer |
0 |
0.39 |
| Generalized Anxiety Disorder |
0 |
0.35 |
| Face |
0 |
0.27 |
| Psychotherapy |
0 |
0.27 |
| Quality of Life |
0 |
0.22 |
| Healthcare and Medical Technology |
0 |
0.21 |
| New York |
0 |
0.16 |
| Clinical Research |
0 |
0.11 |
| Michigan |
0 |
0.11 |
| Patient Safety |
0 |
0.09 |
| Increased Blood Pressure |
0 |
0.08 |
| Xerostomia |
0 |
0.08 |
| Adverse Effects |
0 |
0.06 |
| Antidepressant drug |
0 |
0.06 |
| Arrhythmia |
0 |
0.06 |
| Artificial Intelligence |
0 |
0.06 |
| Blood |
0 |
0.06 |
| Breast |
0 |
0.06 |
| Cardiovascular Risk Management |
0 |
0.06 |
| Child |
0 |
0.06 |
| Depression |
0 |
0.06 |
| Fatigue |
0 |
0.06 |
| Food and Drug Administration (FDA) |
0 |
0.06 |
| Hallucination |
0 |
0.06 |
| Hospital |
0 |
0.06 |
| Hypertension |
0 |
0.06 |
| Maryland |
0 |
0.06 |
| Meta-Analysis |
0 |
0.06 |
| Mouth |
0 |
0.06 |
| Nausea |
0 |
0.06 |
| Neoplasm |
0 |
0.06 |
| Post-Traumatic Stress Disorder |
0 |
0.06 |
| Prostate |
0 |
0.06 |
| Referral |
0 |
0.06 |
| Refractory |
0 |
0.06 |
| Sleep |
0 |
0.06 |
| Stress |
0 |
0.06 |
| Tachycardia |
0 |
0.06 |
| Tumor |
0 |
0.06 |